1. 国家自然科学基金，81973117，血浆氧化应激标志物水平与青年人急性心肌梗死间关系的研究，2020/01-2023/12，55万元，在研，主持

2. 北京协和医学院教学改革项目, 2019E-JG109，研究生学位论文常见问题分析及规范撰写培训教材和课件开发，2019/05-2021/05，10万元，在研，主持

3. 北京市科技计划项目，Z181100001718200，VE/ VC02及相关参数在肺动脉高压早期筛查中应用研究， 2018/01-2021/12，16万元，在研，参加

4. 中国医学科学院医学与健康科技创新工程项目，2017-I2M-1-004，环境及表观遗传与高血压、冠心病早期干预，2017/01-2020/12，810万元，在研，参加

5. “十三五”国家重点研发计划，2016YFC0905602，特征性生物标志物及影像技术在肺栓塞精细化诊断中的应用研究，2016/01-2020/12，132万元，在研，参加

6. 卫生行业科研专项，201402002，西藏和新疆地区慢性心肺疾病现状调查，2014.01-2017.12, 1046万元，已结题，参加

7. “十二五”国家科技支撑计划，2012BAJ18B04，农村心脑血管病防治养分技术集成与应用示范研究，2012.01-2014.12, 548万元，已结题，参加

8. “十二五”国家科技支撑计划，2011BAI11B01，中国重要心血管病患病率调查及关键技术研究，2012.01-2015.12, 2999万元，已结题，参加

9. 国家自然科学基金，30901237，人群血清抵抗素水平的变化规律及其与同期体重变化间关系的研究，2010.01-2012.12, 22万元，已结题，主持

近年发表的部分文章: 

1. Zhang L, Wang Z, Wang X, Chen Z,Shao L, Tian Y, Dong Y, Zheng C, Li S, Zhu M, Gao R; China Hypertension Surveyinvestigators. Prevalence of overweight and obesity in China: Results from across-sectional study of 441 thousand adults, 2012-2015. Obes ResClin Pract. 2020;14(2):119-126. doi:10.1016/j.orcp.2020.02.005

2. Hao G, Wang X, Chen Z, Zhang L,Zhang Y, Wei B, Zheng C, Kang Y, Jiang L, Zhu Z, Zhang J, Wang Z, Gao R; ChinaHypertension Survey Investigators. Prevalence of heart failure and leftventricular dysfunction in China: the China Hypertension Survey, 2012-2015[published correction appears in Eur J Heart Fail. 2020 Apr;22(4):759]. Eur JHeart Fail. 2019;21(11):1329-1337. doi:10.1002/ejhf.1629

3. Kang Y, Han Y, Guan T, Wang X, Xue T,Chen Z, Jiang L, Zhang L, Zheng C, Wang Z, Gao R; China HypertensionSurvey investigators. Clinical blood pressure responses to daily ambienttemperature exposure in China: An analysis based on a representative nationwidepopulation. Sci Total Environ. 2020;705:135762.doi:10.1016/j.scitotenv.2019.135762

4. Wang Z, Hao G, Wang X, Chen Z, ZhangL, Zhang Z, Hu H, Weintraub WS, Gao R; China hypertension surveyinvestigators.. Clinical outcomes and economic impact of the 2017 ACC/AHAguidelines on hypertension in China. J Clin Hypertens (Greenwich).2019;21(8):1212-1220. doi:10.1111/jch.13609

5. Zheng C, Chen Z, Zhang L, Wang X,Dong Y, Wang J, Shao L, Tian Y, Wang Z.. Metabolic Risk Factors and LeftVentricular Diastolic Function in Middle-Aged Chinese Living in the TibetanPlateau. J Am Heart Assoc. 2019;8(6):e010454. doi:10.1161/JAHA.118.010454

6. Wang Z, Wang X, Hao G, Chen Z, ZhangL, Shao L, Tian Y, Dong Y, Zheng C, Kang Y, Gao R; China hypertensionsurvey investigators. A national study of the prevalence and risk factorsassociated with peripheral arterial disease from China: The China HypertensionSurvey, 2012-2015. Int J Cardiol. 2019;275:165-170. doi:10.1016/j.ijcard.2018.10.047

7. Zhang L, Wang Z, Wang X, Chen Z,Shao L, Tian Y, Dong Y, Zheng C, Li S, Zhu M, Gao R; China Hypertension Surveyinvestigators. Prevalence of Abdominal Obesity in China: Results from aCross-Sectional Study of Nearly Half a Million Participants. Obesity (SilverSpring). 2019;27(11):1898-1905. doi:10.1002/oby.22620

8. Dong Y, Wang X, Zhang L, Chen Z, Zheng C,Wang J, Kang Y, Shao L, Tian Y, Wang Z; China CVD study investigators.High-sensitivity C reactive protein and risk of cardiovascular disease inChina-CVD study. J Epidemiol Community Health. 2019;73(2):188-192. doi:10.1136/jech-2018-211433.

9. Dong Y, Hao G, Wang Z, Wang X, Chen Z, ZhangL. Ideal Cardiovascular Health Status and Risk of Cardiovascular Disease orAll-Cause Mortality in Chinese Middle-Aged Population. Angiology.2019;70(6):523-529. doi:10.1177/0003319718813448

10. Wang Z, Chen Z, Zhang L, Wang X,Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, Wang J, Zhu M, Weintraub WS,Gao R; China Hypertension Survey Investigators. Status of Hypertension inChina: Results From the China Hypertension Survey, 2012-2015. Circulation.2018;137(22):2344-2356. doi:10.1161/CIRCULATIONAHA.117.032380

11. Wang Z, Chen Z, Wang X, Zhang L,Li S, Tian Y, Shao L, Hu H, Gao R; for China Hypertension Survey Group.. TheDisease Burden of Atrial Fibrillation in China from a National Cross-sectionalSurvey. Am J Cardiol. 2018;122(5):793-798. doi:10.1016/j.amjcard.2018.05.015

12. Shen Y, Wang X, Wang Z, Zhang L,Chen Z, Zhu M, Chang C, Gao R; China Hypertension Survey Group: TheStandardized Management of Hypertensive Employees Program. Prevalence,awareness, treatment, and control of hypertension among Chinese workingpopulation: results of a workplace-based study. J Am Soc Hypertens.2018;12(4):311-322.e2. doi:10.1016/j.jash.2018.01.013

13. Zhang L, Wang Z, Chen Y, Wang X,Chen Z, Feng B, Zhu Q, Nie J, Dong Y, Zhou S, Tian Y, Shao L, Zhu M. Prevalenceand risk factors associated with chronic kidney disease in adults living in 3different altitude regions in the Tibetan Plateau. Clin Chim Acta.2018;481:212-217. doi:10.1016/j.cca.2018.03.025

14. Dong Y, Wang Z, Chen Z, Wang X, ZhangL, Nie J, Zheng C, Wang J, Shao L, Tian Y, Gao R. Comparison of visceral,body fat indices and anthropometric measures in relation to chronic kidneydisease among Chinese adults from a large scale cross-sectional study. BMCNephrol. 2018;19(1):40. Published 2018 Feb 17. doi:10.1186/s12882-018-0837-1

15. Zhang L, Wang Z, Chen Z, Wang X,Tian Y, Shao L, Zhu M. Central Aortic Systolic Blood Pressure ExhibitsAdvantages Over Brachial Blood Pressure Measurements in Chronic Kidney DiseaseRisk Prediction in Women. Kidney Blood Press Res. 2018;43(4):1375-1387.doi:10.1159/000492952